Epidemiology
Hepatitis B virus genotype D does not influence chronicity in India
Published in Hepatitis Weekly, March 31st, 2003
According to a study from India, "to determine hepatitis B virus genotype and subtype distribution among HBV infected individuals with different clinical manifestations in western India, serum samples from 19 asymptomatic hepatitis B surface antigen carriers, 30 chronic hepatitis B patients, 8 acute hepatitis B patients, 5 fulminant hepatitis B patients, and with circulating HBV DNA were genotyped and subtyped on the basis of the nucleotide sequence analysis of S region of the HBV genome."
"Genotype D was the predominant genotype circulating in western India (57/62; 91.93%),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-03-31)
More Articles from Hepatitis Weekly
- Biomarkers
Genotype, enzyme levels, and viral load are clues to hepatitis C virus outcomes - Chronic Hepatitis C
Hepatitis B infection has no impact on hepatitis C response to interferon - Acute Hepatitis B
Coinfecting viruses don't change the kinetics of acute HBV infection - Chronic Hepatitis B
Alternate pathways regulate the life cycle of hepatitis B virus - Hepatitis C Virus
Herpes simplex viruses would be useful for exploring hepatitis C NS5A protein - Virology
Evolution of hepatitis C virus in blood donors differs from that of recipients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
